Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Net Income (2020 - 2025)

LifeStance Health (LFST) has disclosed Net Income for 6 consecutive years, with $13.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Net Income rose 269.59% to $13.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $11.7 million, a 120.0% increase, with the full-year FY2025 number at $11.7 million, up 120.0% from a year prior.
  • Net Income was $13.7 million for Q4 2025 at LifeStance Health, up from $1.1 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $13.7 million in Q4 2025 to a low of -$119.4 million in Q3 2021.
  • A 5-year average of -$37.2 million and a median of -$36.0 million in 2022 define the central range for Net Income.
  • Peak YoY movement for Net Income: tumbled 1463.91% in 2021, then surged 269.59% in 2025.
  • LifeStance Health's Net Income stood at -$101.7 million in 2021, then skyrocketed by 54.13% to -$46.7 million in 2022, then rose by 3.64% to -$45.0 million in 2023, then skyrocketed by 82.05% to -$8.1 million in 2024, then soared by 269.59% to $13.7 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Net Income are $13.7 million (Q4 2025), $1.1 million (Q3 2025), and -$3.8 million (Q2 2025).